SCHEMBL23620164

SCHEMBL23620164

O=S(=O)(O)c1c[nH]c2c1ccc1ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 1/20 0.50
▸ CSNK2B P67870 1/20 0.50
▸ CSNK2A1 P68400 1/20 0.50
▸ CTRB1 P17538 1/20 0.43
▸ MPL P40238 4/20 0.42
▸ CTRC Q99895 2/20 0.42
▸ KIF11 P52732 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.39
▸ HSD17B10 Q99714 4/20 0.39
▸ HPGD P15428 3/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HPRT1 P00492 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30991305 1.00 CSNK2A2 (0.50) CSNK2A2CSNK2BCSNK2A1CTRB1MPL
SCHEMBL30286837 0.83 CSNK2A2 (0.46) CSNK2A2CSNK2BCSNK2A1KIF11ALDH1A1
SCHEMBL20354813 0.83 CSNK2A2 (0.46) CSNK2A2CSNK2BCSNK2A1KIF11ALDH1A1
SCHEMBL20354762 0.79 TET2 (0.56) ALDH1A1HSD17B10HPGDKDM4EHTT
SCHEMBL29559685 0.79 TET2 (0.56) ALDH1A1HSD17B10HPGDKDM4EHTT
Hydrochloric Acid SCHEMBL28316509 0.77 TET2 (0.55) ALDH1A1HSD17B10HPGDKDM4EHTT
SCHEMBL14836474 0.77 HTR2A (0.44) CSNK2A2CSNK2BCSNK2A1CTRB1MPL
SCHEMBL6478098 0.76 NR4A2 (0.49) CA1CA2CA9
SCHEMBL329511 0.74 SLC22A6 (0.56) ALDH1A1MEN1KMT2AMAPTCYP2A6
SCHEMBL8479026 0.73 SLC22A6 (0.54) ALDH1A1MEN1KMT2AMAPTCYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 — — US disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 — — US disclosed
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides UCB PHARMA GMBH (DE) 2024-03-26 — — US disclosed
EP-4074703-B1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2023-11-29 — — EP disclosed
EP-4074703-B1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2023-11-29 — — EP disclosed
EP-4074703-A1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB Pharma GmbH (DE) 2022-10-19 — — EP disclosed
EP-4074703-A1 PYRIDINYL-(AZA)INDOLSULFONAMIDES UCB Pharma GmbH (DE) 2022-10-19 — — EP disclosed
EP-3810591-B1 PYRIDINYL AND PYRAZINYL-(AZA)INDOLSULFONAMIDES UCB PHARMA GMBH (DE) 2022-08-10 — — EP disclosed
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides UCB PHARMA GMBH (DE) 2021-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210206749-A1 Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides GPR17, GPR18, GPR119 CSNK2A2 2491/4885CSNK2B 2562/4885CSNK2A1 2404/4885
US-11939319-B2 Pyridinyl and pyrazinyl-(asa)indolsulfonamides GPR17, GPR18, GPR119 CSNK2A2 2491/4885CSNK2B 2562/4885CSNK2A1 2404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback